Compliance Rate

Compliance Rate 48.0%
Compliant submissions 48
Incompliant submissions 52
Total trials 100

Your Clinical Trials

Showing 100 of 100 entries
View as:

Rapid Early Action for Coronary Treatment (REACT)

Phase: N/A Priority: Normal
NCT ID: NCT00000550 Org: User:
Start: 08/31/94 End: 05/31/00 Due: 05/31/01

Comparison of Three Treatments for Pneumocystis Pneumonia in AIDS Patients

Phase: N/A Priority: Normal
NCT ID: NCT00000730 Org: User:
Start: - End: 03/31/89 Due: 03/31/90

A Phase II Study of Low-Dose Interleukin-2 by Subcutaneous Injection in Combination With Antiretroviral Therapy Versus Antiretroviral Therapy Alone in Patients With HIV-1 Infection and at Least 3 Months Stable Antiretroviral Therapy

Phase: N/A Priority: Normal
NCT ID: NCT00000820 Org: User:
Start: - End: 03/31/02 Due: 03/31/03

Safety of Estrogens in Lupus: Birth Control Pills

Phase: N/A Priority: Normal
NCT ID: NCT00000420 Org: User:
Start: 06/30/97 End: 08/31/03 Due: 08/31/04

Interruption of Maternal-to-Infant Transmission of Hepatitis B by Means of Hepatitis B Immune Globulin

Phase: N/A Priority: Normal
NCT ID: NCT00000580 Org: User:
Start: 11/30/75 End: 06/30/86 Due: 06/30/87

Human Surfactant Treatment of Respiratory Distress Syndrome Bicenter Trial

Phase: N/A Priority: Normal
NCT ID: NCT00000570 Org: User:
Start: 01/31/86 End: 06/30/90 Due: 06/30/91

Cocaine in Parotid Saliva, Blood and Urine - 4

Phase: N/A Priority: Normal
NCT ID: NCT00000190 Org: User:
Start: 01/31/91 End: 02/29/92 Due: 02/28/93

Serotonin/Dopamine Antagonism of Cocaine Effect: 2 - 2

Phase: N/A Priority: Normal
NCT ID: NCT00000310 Org: User:
Start: 01/31/96 End: 03/31/96 Due: 03/31/97

Brain Imaging: Cocaine Effects & Medication Development - 5

Phase: N/A Priority: Normal
NCT ID: NCT00000270 Org: User:
Start: 12/30/95 End: 12/30/95 Due: 12/30/96

Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment II-2 - 5

Phase: N/A Priority: Normal
NCT ID: NCT00000330 Org: User:
Start: 10/31/99 End: 11/30/99 Due: 11/30/00

Metabolism of Antituberculosis Drugs in HIV-Infected Persons With Tuberculosis

Phase: N/A Priority: Normal
NCT ID: NCT00000950 Org: User:
Start: - End: - Due: -

Growth Hormone Releasing Hormone (GHRH) Treatment for Age-Related Sleep Disturbances

Phase: N/A Priority: Normal
NCT ID: NCT00000380 Org: User:
Start: 06/30/96 End: 07/31/07 Due: 07/31/08

Single Dose Pharmacokinetics of Oral Dextran Sulfate (UA001) and Intravenous Dextran Sulfate in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT00000690 Org: User:
Start: - End: 10/31/89 Due: 10/31/90

A Phase I Study of Autologous, Activated CD8(+) Lymphocytes Expanded In Vitro and Infused With or Without Recombinant Interleukin-2 to Patients With AIDS or Severe ARC

Phase: N/A Priority: Normal
NCT ID: NCT00000680 Org: User:
Start: - End: 04/30/93 Due: 04/30/94

A Study to Evaluate the Effect of Anti-HIV Therapy on Lean Tissue (Muscle) in HIV-Positive Patients

Phase: N/A Priority: Normal
NCT ID: NCT00000890 Org: User:
Start: - End: - Due: -

Thalidomide for Treatment of Oral and Esophageal Aphthous Ulcers and HIV Viremia in Patients With HIV Infection

Phase: N/A Priority: Normal
NCT ID: NCT00000790 Org: User:
Start: - End: 10/31/98 Due: 10/31/99

Phase I Study of Weekly Oral VP-16 for AIDS-Associated Kaposi's Sarcoma

Phase: N/A Priority: Normal
NCT ID: NCT00000660 Org: User:
Start: - End: 07/31/92 Due: 07/31/93

Endophthalmitis Vitrectomy Study (EVS)

Phase: N/A Priority: Normal
NCT ID: NCT00000130 Org: User:
Start: 02/28/90 End: 01/31/95 Due: 01/31/96

Action to Control Cardiovascular Risk in Diabetes (ACCORD)

Phase: N/A Priority: Normal
NCT ID: NCT00000620 Org: User:
Start: 09/30/99 End: 12/31/12 Due: 12/31/13

Influence of Diet and Endurance Running on Intramuscular Lipids Measured at 4.1 TESLA

Phase: N/A Priority: Normal
NCT ID: NCT00000110 Org: User:
Start: - End: - Due: -

The Safety and Effectiveness of Zidovudine in HIV-Infected Pregnant Women and Their Infants

Phase: N/A Priority: Normal
NCT ID: NCT00000960 Org: User:
Start: - End: 06/30/94 Due: 06/30/95

Raynaud's Treatment Study (RTS)

Phase: N/A Priority: Normal
NCT ID: NCT00000530 Org: User:
Start: 09/30/92 End: 06/30/98 Due: 06/30/99

Methadone Effects on Zidovudine (ZDV, AZT) Disposition

Phase: N/A Priority: Normal
NCT ID: NCT00000800 Org: User:
Start: - End: 10/31/98 Due: 10/31/99

An Assessment of the In Vivo Biological Effects of Diethyldithiocarbamate (DTC) in HIV-Infected Patients

Phase: N/A Priority: Normal
NCT ID: NCT00000650 Org: User:
Start: - End: 09/30/96 Due: 09/30/97

Submacular Surgery Trials (SST)

Phase: N/A Priority: Normal
NCT ID: NCT00000150 Org: User:
Start: 01/31/99 End: 09/30/01 Due: 09/30/02